Role of bile acids in colon carcinogenesis
|
摘要
Bile acids(BAs)are cholesterol derivatives synthesized in the liver and then secreted into the intestine for lipid absorption.There are numerous scientific reports describing BAs,especially secondary BAs,as strong carcinogens or promoters of colon cancers.Firstly,BAs act as strong stimulators of colorectal cancer(CRC)initiation by damaging colonic epithelial cells,and inducing reactive oxygen species production,genomic destabilization,apoptosis resistance,and cancer stem cells-like formation.Consequently,BAs promote CRC progression via multiple mechanisms,including inhibiting apoptosis,enhancing cancer cell proliferation,invasion,and angiogenesis.There are diverse signals involved in the carcinogenesis mechanism of BAs,with a major role of epidermal growth factor receptor,and its down-stream signaling,involving mitogen-activated protein kinase,phosphoinositide 3-kinase/Akt,and nuclear factor kappa-light-chain-enhancer of activated B cells.BAs regulate numerous genes including the human leukocyte antigen class I gene,p53,matrix metalloprotease,urokinase plasminogen activator receptor,Cyclin D1,cyclooxygenase-2,interleukin-8,and miRNAs of CRC cells,leading to CRC promotion.These evidence suggests that targeting BAs is an efficacious strategies for CRC prevention and treatment.
Bile acids(BAs)are cholesterol derivatives synthesized in the liver and then secreted into the intestine for lipid absorption.There are numerous scientific reports describing BAs,especially secondary BAs,as strong carcinogens or promoters of colon cancers.Firstly,BAs act as strong stimulators of colorectal cancer(CRC)initiation by damaging colonic epithelial cells,and inducing reactive oxygen species production,genomic destabilization,apoptosis resistance,and cancer stem cells-like formation.Consequently,BAs promote CRC progression via multiple mechanisms,including inhibiting apoptosis,enhancing cancer cell proliferation,invasion,and angiogenesis.There are diverse signals involved in the carcinogenesis mechanism of BAs,with a major role of epidermal growth factor receptor,and its down-stream signaling,involving mitogen-activated protein kinase,phosphoinositide 3-kinase/Akt,and nuclear factor kappa-light-chain-enhancer of activated B cells.BAs regulate numerous genes including the human leukocyte antigen class I gene,p53,matrix metalloprotease,urokinase plasminogen activator receptor,Cyclin D1,cyclooxygenase-2,interleukin-8,and miRNAs of CRC cells,leading to CRC promotion.These evidence suggests that targeting BAs is an efficacious strategies for CRC prevention and treatment.
Bile acids(BAs)are cholesterol derivatives synthesized in the liver and then secreted into the intestine for lipid absorption.There are numerous scientific reports describing BAs,especially secondary BAs,as strong carcinogens or promoters of colon cancers.Firstly,BAs act as strong stimulators of colorectal cancer(CRC)initiation by damaging colonic epithelial cells,and inducing reactive oxygen species production,genomic destabilization,apoptosis resistance,and cancer stem cells-like formation.Consequently,BAs promote CRC progression via multiple mechanisms,including inhibiting apoptosis,enhancing cancer cell proliferation,invasion,and angiogenesis.There are diverse signals involved in the carcinogenesis mechanism of BAs,with a major role of epidermal growth factor receptor,and its down-stream signaling,involving mitogen-activated protein kinase,phosphoinositide 3-kinase/Akt,and nuclear factor kappa-light-chain-enhancer of activated B cells.BAs regulate numerous genes including the human leukocyte antigen class I gene,p53,matrix metalloprotease,urokinase plasminogen activator receptor,Cyclin D1,cyclooxygenase-2,interleukin-8,and miRNAs of CRC cells,leading to CRC promotion.These evidence suggests that targeting BAs is an efficacious strategies for CRC prevention and treatment.
引文
1 Monte MJ,Marin JJ,Antelo A,Vazquez-Tato J.Bile acids:chemistry,physiology,and pathophysiology.World J Gastroenterol2009;15:804-816[PMID:19230041 DOI:10.3748/wjg.15.804]
2 Schaap FG,Trauner M,Jansen PL.Bile acid receptors as targets for drug development.Nat Rev Gastroenterol Hepatol 2014;11:55-67[PMID:23982684 DOI:10.1038/nrgastro.2013.151]
3 Mertens KL,Kalsbeek A,Soeters MR,Eggink HM.Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System.Front Neurosci 2017;11:617[PMID:29163019 DOI:10.3389/fnins.2017.00617]
4 Kullak-Ublick GA,Stieger B,Meier PJ.Enterohepatic bile salt transporters in normal physiology and liver disease.Gastroenterology 2004;126:322-342[PMID:14699511 DOI:10.1053/j.gastro.2003.06.005]
5 Li T,Chiang JY.Bile acid signaling in metabolic disease and drug therapy.Pharmacol Rev 2014;66:948-983[PMID:25073467DOI:10.1124/pr.113.008201]
6 Thomas C,Pellicciari R,Pruzanski M,Auwerx J,Schoonjans K.Targeting bile-acid signalling for metabolic diseases.Nat Rev Drug Discov 2008;7:678-693[PMID:18670431 DOI:10.1038/nrd2619]
7 Chiang JY.Regulation of bile acid synthesis:pathways,nuclear receptors,and mechanisms.J Hepatol 2004;40:539-551[PMID:15123373 DOI:10.1016/j.jhep.2003.11.006]
8 Twisk J,Hoekman MF,Lehmann EM,Meijer P,Mager WH,Princen HM.Insulin suppresses bile acid synthesis in cultured rat hepatocytes by down-regulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase gene transcription.Hepatology 1995;21:501-510[PMID:7843724]
9 Song Y,Xu C,Shao S,Liu J,Xing W,Xu J,Qin C,Li C,Hu B,Yi S,Xia X,Zhang H,Zhang X,Wang T,Pan W,Yu C,Wang Q,Lin X,Wang L,Gao L,Zhao J.Thyroid-stimulating hormone regulates hepatic bile acid homeostasis via SREBP-2/HNF-4α/CYP7A1 axis.J Hepatol 2015;62:1171-1179[PMID:25533663 DOI:10.1016/j.jhep.2014.12.006]
10 Wagner M,Halilbasic E,Marschall HU,Zollner G,Fickert P,Langner C,Zatloukal K,Denk H,Trauner M.CAR and PXRagonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.Hepatology 2005;42:420-430[PMID:15986414 DOI:10.1002/hep.20784]
11 Li T,Chiang JY.Mechanism of rifampicin and pregnane Xreceptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription.Am J Physiol Gastrointest Liver Physiol 2005;288:G74-G84[PMID:15331348 DOI:10.1152/ajpgi.00258.2004]
12 Bhalla S,Ozalp C,Fang S,Xiang L,Kemper JK.Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha.Functional implications in hepatic cholesterol and glucose metabolism.J Biol Chem2004;279:45139-45147[PMID:15322103 DOI:10.1074/jbc.M405423200]
13 Vlachova M,Blahova T,Lanska V,Lení?ek M,Pitha J,Vítek L,Kovar J.Diurnal variation in cholesterol 7α-hydroxylase activity is determined by the-203A>C polymorphism of the CYP7A1gene.Croat Med J 2016;57:111-117[PMID:27106353 DOI:10.3325/cmj.2016.57.111]
14 Kovár J,Lenícek M,ZimolováM,Vítek L,Jirsa M,Pitha J.Regulation of diurnal variation of cholesterol 7alpha-hydroxylase(CYP7A1)activity in healthy subjects.Physiol Res 2010;59:233-238[PMID:19537927]
15 Nagengast FM,Grubben MJ,van Munster IP.Role of bile acids in colorectal carcinogenesis.Eur J Cancer 1995;31:1067-1070[PMID:7576993 DOI:10.1016/0959-8049(95)00216-6]
16 Bayerd?rffer E,Mannes GA,Richter WO,Ochsenkühn T,Wiebecke B,K?pcke W,Paumgartner G.Increased serum deoxycholic acid levels in men with colorectal adenomas.Gastroenterology 1993;104:145-151[PMID:8419237 DOI:10.1016/0016-5085(93)90846-5]
17 Bayerd?rffer E,Mannes GA,Ochsenkühn T,Dirschedl P,Wiebecke B,Paumgartner G.Unconjugated secondary bile acids in the serum of patients with colorectal adenomas.Gut 1995;36:268-273[PMID:7883228 DOI:10.1136/gut.36.2.268]
18 Tong JL,Ran ZH,Shen J,Fan GQ,Xiao SD.Association between fecal bile acids and colorectal cancer:a meta-analysis of observational studies.Yonsei Med J 2008;49:792-803[PMID:18972600 DOI:10.3349/ymj.2008.49.5.792]
19 Imray CH,Radley S,Davis A,Barker G,Hendrickse CW,Donovan IA,Lawson AM,Baker PR,Neoptolemos JP.Faecal unconjugated bile acids in patients with colorectal cancer or polyps.Gut 1992;33:1239-1245[PMID:1427378 DOI:10.1136/gut.33.9.1239]
20 Kirkegaard H,Johnsen NF,Christensen J,Frederiksen K,Overvad K,Tj?nneland A.Association of adherence to lifestyle recommendations and risk of colorectal cancer:a prospective Danish cohort study.BMJ 2010;341:c5504[PMID:20978063DOI:10.1136/bmj.c5504]
21 Jenkins DJ,Wolever TM,Rao AV,Hegele RA,Mitchell SJ,Ransom TP,Boctor DL,Spadafora PJ,Jenkins AL,Mehling C.Effect on blood lipids of very high intakes of fiber in diets low in saturated fat and cholesterol.N Engl J Med 1993;329:21-26[PMID:8389421 DOI:10.1056/NEJM199307013290104]
22 Ghaffarzadegan T,Zhong Y,F?k H?llenius F,Nyman M.Effects of barley variety,dietary fiber andβ-glucan content on bile acid composition in cecum of rats fed low-and high-fat diets.J Nutr Biochem 2018;53:104-110[PMID:29202273 DOI:10.1016/j.jnutbio.2017.10.008]
23 Newmark HL,Yang K,Kurihara N,Fan K,Augenlicht LH,Lipkin M.Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice:a preclinical model for human sporadic colon cancer.Carcinogenesis 2009;30:88-92[PMID:19017685 DOI:10.1093/carcin/bgn229]
24 Thummel KE,Brimer C,Yasuda K,Thottassery J,Senn T,Lin Y,Ishizuka H,Kharasch E,Schuetz J,Schuetz E.Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3.Mol Pharmacol 2001;60:1399-1406[PMID:11723248 DOI:10.1124/mol.60.6.1399]
25 Kawaura A,Tanida N,Sawada K,Oda M,Shimoyama T.Supplemental administration of 1 alpha-hydroxyvitamin D3inhibits promotion by intrarectal instillation of lithocholic acid in N-methyl-N-nitrosourea-induced colonic tumorigenesis in rats.Carcinogenesis 1989;10:647-649[PMID:2702712 DOI:10.1093/carcin/10.4.647]
26 Makishima M,Lu TT,Xie W,Whitfield GK,Domoto H,Evans RM,Haussler MR,Mangelsdorf DJ.Vitamin D receptor as an intestinal bile acid sensor.Science 2002;296:1313-1316[PMID:12016314 DOI:10.1126/science.1070477]
27 Newmark HL,Wargovich MJ,Bruce WR.Colon cancer and dietary fat,phosphate,and calcium:a hypothesis.J Natl Cancer Inst 1984;72:1323-1325[PMID:6587152]
28 Payne CM,Bernstein C,Dvorak K,Bernstein H.Hydrophobic bile acids,genomic instability,Darwinian selection,and colon carcinogenesis.Clin Exp Gastroenterol 2008;1:19-47[PMID:21677822 DOI:10.2147/CEG.S4343]
29 Ochsenkühn T,Bayerd?rffer E,Meining A,Schinkel M,Thiede C,Nüssler V,Sackmann M,Hatz R,Neubauer A,Paumgartner G.Colonic mucosal proliferation is related to serum deoxycholic acid levels.Cancer 1999;85:1664-1669[PMID:10223558DOI:10.1002/(SICI)1097-0142(19990415)85:8<1664::AID-CNCR4>3.0.CO;2-O]
30 Ajouz H,Mukherji D,Shamseddine A.Secondary bile acids:an underrecognized cause of colon cancer.World J Surg Oncol 2014;12:164[PMID:24884764 DOI:10.1186/1477-7819-12-164]
31 Degirolamo C,Modica S,Palasciano G,Moschetta A.Bile acids and colon cancer:Solving the puzzle with nuclear receptors.Trends Mol Med 2011;17:564-572[PMID:21724466 DOI:10.1016/j.molmed.2011.05.010]
32 Bernstein H,Bernstein C,Payne CM,Dvorak K.Bile acids as endogenous etiologic agents in gastrointestinal cancer.World J Gastroenterol 2009;15:3329-3340[PMID:19610133 DOI:10.3748/wjg.15.3329]
33 Qiao D,Gaitonde SV,Qi W,Martinez JD.Deoxycholic acid suppresses p53 by stimulating proteasome-mediated p53 protein degradation.Carcinogenesis 2001;22:957-964[PMID:11375905DOI:10.1093/carcin/22.6.957]
34 Turner DJ,Alaish SM,Zou T,Rao JN,Wang JY,Strauch ED.Bile salts induce resistance to apoptosis through NF-kappaB-mediated XIAP expression.Ann Surg 2007;245:415-425[PMID:17435549DOI:10.1097/01.sla.0000236631.72698.99]
35 Farhana L,Nangia-Makker P,Arbit E,Shango K,Sarkar S,Mahmud H,Hadden T,Yu Y,Majumdar AP.Bile acid:a potential inducer of colon cancer stem cells.Stem Cell Res Ther 2016;7:181[PMID:27908290 DOI:10.1186/s13287-016-0439-4]
36 Rodrigues C?MP,Castro RE,Steer CJ.The role of bile acids in the modulation of apoptosis:Elsevier Ltd,2004,15:119-145
37 Ignacio Barrasa J,Olmo N,Pérez-Ramos P,Santiago-Gómez A,Lecona E,Turnay J,Antonia Lizarbe M.Deoxycholic and chenodeoxycholic bile acids induce apoptosis via oxidative stress in human colon adenocarcinoma cells.Apoptosis 2011;16:1054-1067[PMID:21789651 DOI:10.1007/s10495-011-0633-x]
38 Yui S,Kanamoto R,Saeki T.Biphasic regulation of cell death and survival by hydrophobic bile acids in HCT116 cells.Nutr Cancer2009;61:374-380[PMID:19373611 DOI:10.1080/01635580802582744]
39 Shant J,Cheng K,Marasa BS,Wang JY,Raufman JP.Aktdependent NF-kappaB activation is required for bile acids to rescue colon cancer cells from stress-induced apoptosis.Exp Cell Res 2009;315:432-450[PMID:19056378 DOI:10.1016/j.yexcr.2008.11.003]
40 Raufman JP,Shant J,Guo CY,Roy S,Cheng K.Deoxycholyltaurine rescues human colon cancer cells from apoptosis by activating EGFR-dependent PI3K/Akt signaling.J Cell Physiol 2008;215:538-549[PMID:18064605 DOI:10.1002/jcp.21332]
41 Cheng K,Raufman JP.Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors.Biochem Pharmacol 2005;70:1035-1047[PMID:16139803 DOI:10.1016/j.bcp.2005.07.023]
42 Cao H,Luo S,Xu M,Zhang Y,Song S,Wang S,Kong X,He N,Cao X,Yan F,Wang B.The secondary bile acid,deoxycholate accelerates intestinal adenoma-adenocarcinoma sequence in Apc(min/+)mice through enhancing Wnt signaling.Fam Cancer 2014;13:563-571[PMID:25106466 DOI:10.1007/s10689-014-9742-3]
43 Dermadi D,Valo S,Ollila S,Soliymani R,Sipari N,Pussila M,Sarantaus L,Linden J,Baumann M,Nystr?m M.Western Diet Deregulates Bile Acid Homeostasis,Cell Proliferation,and Tumorigenesis in Colon.Cancer Res 2017;77:3352-3363[PMID:28416481 DOI:10.1158/0008-5472.CAN-16-2860]
44 Pai R,Tarnawski AS,Tran T.Deoxycholic acid activates betacatenin signaling pathway and increases colon cell cancer growth and invasiveness.Mol Biol Cell 2004;15:2156-2163[PMID:15004225 DOI:10.1091/mbc.e03-12-0894]
45 Baek MK,Park JS,Park JH,Kim MH,Kim HD,Bae WK,Chung IJ,Shin BA,Jung YD.Lithocholic acid upregulates uPAR and cell invasiveness via MAPK and AP-1 signaling in colon cancer cells.Cancer Lett 2010;290:123-128[PMID:19782465 DOI:10.1016/j.canlet.2009.08.030]
46 Debruyne PR,Bruyneel EA,Karaguni IM,Li X,Flatau G,Müller O,Zimber A,Gespach C,Mareel MM.Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathways.Oncogene 2002;21:6740-6750[PMID:12360401 DOI:10.1038/sj.onc.1205729]
47 Nishida N,Yano H,Nishida T,Kamura T,Kojiro M.Angiogenesis in cancer.Vasc Health Risk Manag 2006;2:213-219[PMID:17326328 DOI:10.2147/vhrm.2006.2.3.213]
48 Mühlbauer M,Allard B,Bosserhoff AK,Kiessling S,Herfarth H,Rogler G,Sch?lmerich J,Jobin C,Hellerbrand C.Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-kappa B signal transduction and IL-8 gene expression in colonic epithelial cells.Am J Physiol Gastrointest Liver Physiol 2004;286:G1000-G1008[PMID:14726307 DOI:10.1152/ajpgi.00338.2003]
49 Nguyen TT,Lian S,Ung TT,Xia Y,Han JY,Jung YD.Lithocholic Acid Stimulates IL-8 Expression in Human Colorectal Cancer Cells Via Activation of Erk1/2 MAPK and Suppression of STAT3Activity.J Cell Biochem 2017;118:2958-2967[PMID:28247965DOI:10.1002/jcb.25955]
50 Per?e M.Oxidative stress in the pathogenesis of colorectal cancer:cause or consequence?Biomed Res Int 2013;2013:725710[PMID:23762854 DOI:10.1155/2013/725710]
51 Ji LL,Gomez-Cabrera MC,Vina J.Exercise and hormesis:activation of cellular antioxidant signaling pathway.Ann N YAcad Sci 2006;1067:425-435[PMID:16804022 DOI:10.1196/annals.1354.061]
52 Ji LL,Gomez-Cabrera MC,Vina J.Role of nuclear factor kappaBand mitogen-activated protein kinase signaling in exercise-induced antioxidant enzyme adaptation.Appl Physiol Nutr Metab 2007;32:930-935[PMID:18059618 DOI:10.1139/H07-098]
53 Payne CM,Weber C,Crowley-Skillicorn C,Dvorak K,Bernstein H,Bernstein C,Holubec H,Dvorakova B,Garewal H.Deoxycholate induces mitochondrial oxidative stress and activates NF-kappaBthrough multiple mechanisms in HCT-116 colon epithelial cells.Carcinogenesis 2007;28:215-222[PMID:16887864 DOI:10.1093/carcin/bgl139]
54 Valko M,Leibfritz D,Moncol J,Cronin MT,Mazur M,Telser J.Free radicals and antioxidants in normal physiological functions and human disease.Int J Biochem Cell Biol 2007;39:44-84[PMID:16978905 DOI:10.1016/j.biocel.2006.07.001]
55 Roberts RB,Min L,Washington MK,Olsen SJ,Settle SH,Coffey RJ,Threadgill DW.Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis.Proc Natl Acad Sci U S A 2002;99:1521-1526[PMID:11818567 DOI:10.1073/pnas.032678499]
56 Nicholson RI,Gee JM,Harper ME.EGFR and cancer prognosis.Eur J Cancer 2001;37 Suppl 4:S9-S15[PMID:11597399 DOI:10.1016/S0959-8049(01)00231-3]
57 Lee HY,Crawley S,Hokari R,Kwon S,Kim YS.Bile acid regulates MUC2 transcription in colon cancer cells via positive EGFR/PKC/Ras/ERK/CREB,PI3K/Akt/IkappaB/NF-kappaBand p38/MSK1/CREB pathways and negative JNK/c-Jun/AP-1pathway.Int J Oncol 2010;36:941-953[PMID:20198339]
58 Musteanu M,Blaas L,Mair M,Schlederer M,Bilban M,Tauber S,Esterbauer H,Mueller M,Casanova E,Kenner L,Poli V,Eferl R.Stat3 is a negative regulator of intestinal tumor progression in Apc(Min)mice.Gastroenterology 2010;138:1003-1011.e1-e5[PMID:19962983 DOI:10.1053/j.gastro.2009.11.049]
59 de Jong PR,Mo JH,Harris AR,Lee J,Raz E.STAT3:An AntiInvasive Factor in Colorectal Cancer?Cancers(Basel)2014;6:1394-1407[PMID:24995503 DOI:10.3390/cancers6031394]
60 Parsons DW,Wang TL,Samuels Y,Bardelli A,Cummins JM,De Long L,Silliman N,Ptak J,Szabo S,Willson JK,Markowitz S,Kinzler KW,Vogelstein B,Lengauer C,Velculescu VE.Colorectal cancer:mutations in a signalling pathway.Nature 2005;436:792[PMID:16094359 DOI:10.1038/436792a]
61 Tucker ON,Dannenberg AJ,Yang EK,Fahey TJ 3rd.Bile acids induce cyclooxygenase-2 expression in human pancreatic cancer cell lines.Carcinogenesis 2004;25:419-423[PMID:14656949DOI:10.1093/carcin/bgh010]
62 Zhu Y,Hua P,Rafiq S,Waffner EJ,Duffey ME,Lance P.Ca2+-and PKC-dependent stimulation of PGE2 synthesis by deoxycholic acid in human colonic fibroblasts.Am J Physiol Gastrointest Liver Physiol 2002;283:G503-G510[PMID:12181161 DOI:10.1152/ajpgi.00525.2001]
63 Cheng K,Chen Y,Zimniak P,Raufman JP,Xiao Y,Frucht H.Functional interaction of lithocholic acid conjugates with M3muscarinic receptors on a human colon cancer cell line.Biochim Biophys Acta 2002;1588:48-55[PMID:12379313 DOI:10.1016/S0925-4439(02)00115-1]
64 Cheng K,Xie G,Raufman JP.Matrix metalloproteinase-7-catalyzed release of HB-EGF mediates deoxycholyltaurineinduced proliferation of a human colon cancer cell line.Biochem Pharmacol 2007;73:1001-1012[PMID:17222808 DOI:10.1016/j.bcp.2006.11.028]
65 Raufman JP,Cheng K,Saxena N,Chahdi A,Belo A,Khurana S,Xie G.Muscarinic receptor agonists stimulate matrix metalloproteinase 1-dependent invasion of human colon cancer cells.Biochem Biophys Res Commun 2011;415:319-324[PMID:22027145 DOI:10.1016/j.bbrc.2011.10.052]
66 Arvind P,Papavassiliou ED,Tsioulias GJ,Duceman BW,Lovelace CI,Geng W,Staiano-Coico L,Rigas B.Lithocholic acid inhibits the expression of HLA class I genes in colon adenocarcinoma cells.Differential effect on HLA-A,-B and-Cloci.Mol Immunol 1994;31:607-614[PMID:8196671 DOI:10.1016/0161-5890(94)90168-6]
67 Halvorsen B,Staff AC,Ligaarden S,Prydz K,Kolset SO.Lithocholic acid and sulphated lithocholic acid differ in the ability to promote matrix metalloproteinase secretion in the human colon cancer cell line CaCo-2.Biochem J 2000;349:189-193[PMID:10861227 DOI:10.1042/bj3490189]
68 Jurek D,Fleckl E,Marian B.Bile acid induced gene expression in LT97 colonic adenoma cells.Food Chem Toxicol 2005;43:87-93[PMID:15582199 DOI:10.1016/j.fct.2004.08.015]
69 Oshio H,Abe T,Onogawa T,Ohtsuka H,Sato T,Ii T,Fukase K,Muto M,Katayose Y,Oikawa M,Rikiyama T,Egawa S,Unno M.Peroxisome proliferator-activated receptor alpha activates cyclooxygenase-2 gene transcription through bile acid transport in human colorectal cancer cell lines.J Gastroenterol 2008;43:538-549[PMID:18648741 DOI:10.1007/s00535-008-2188-3]
70 Zhu Y,Zhu M,Lance P.Stromal COX-2 signaling activated by deoxycholic acid mediates proliferation and invasiveness of colorectal epithelial cancer cells.Biochem Biophys Res Commun 2012;425:607-612[PMID:22885178 DOI:10.1016/j.bbrc.2012.07.137]
71 Glinghammar B,Rafter J.Colonic luminal contents induce cyclooxygenase 2 transcription in human colon carcinoma cells.Gastroenterology 2001;120:401-410[PMID:11159881 DOI:10.1053/gast.2001.21188]
72 Rial NS,Lazennec G,Prasad AR,Krouse RS,Lance P,Gerner EW.Regulation of deoxycholate induction of CXCL8 by the adenomatous polyposis coli gene in colorectal cancer.Int J Cancer2009;124:2270-2280[PMID:19173296 DOI:10.1002/ijc.24226]
73 Wang JY,Wang CL,Wang XM,Liu FJ.Comprehensive analysis of microRNA/mRNA signature in colon adenocarcinoma.Eur Rev Med Pharmacol Sci 2017;21:2114-2129[PMID:28537673]
74 Krattinger R,Bostr?m A,Lee SML,Thasler WE,Schi?th HB,Kullak-Ublick GA,Mwinyi J.Chenodeoxycholic acid significantly impacts the expression of miRNAs and genes involved in lipid,bile acid and drug metabolism in human hepatocytes.Life Sci 2016;156:47-56[PMID:27174168 DOI:10.1016/j.lfs.2016.04.037]
75 Dixit AK,Sarver AE,Yuan Z,George J,Barlass U,Cheema H,Sareen A,Banerjee S,Dudeja V,Dawra R,Subramanian S,Saluja AK.Comprehensive analysis of microRNA signature of mouse pancreatic acini:overexpression of miR-21-3p in acute pancreatitis.Am J Physiol Gastrointest Liver Physiol 2016;311:G974-G980[PMID:27686613 DOI:10.1152/ajpgi.00191.2016]
76 Castro RE,Ferreira DM,Zhang X,Borralho PM,Sarver AL,Zeng Y,Steer CJ,Kren BT,Rodrigues CM.Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid.Am J Physiol Gastrointest Liver Physiol 2010;299:G887-G897[PMID:20689055 DOI:10.1152/ajpgi.00216.2010]
77 Kong Y,Bai PS,Sun H,Nan KJ,Chen NZ,Qi XG.The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.Int J Biochem Cell Biol 2012;44:2321-2332[PMID:22903020 DOI:10.1016/j.biocel.2012.08.006]
78 Bailey AM,Zhan L,Maru D,Shureiqi I,Pickering CR,Kiriakova G,Izzo J,He N,Wei C,Baladandayuthapani V,Liang H,Kopetz S,Powis G,Guo GL.FXR silencing in human colon cancer by DNAmethylation and KRAS signaling.Am J Physiol Gastrointest Liver Physiol 2014;306:G48-G58[PMID:24177031 DOI:10.1152/ajpgi.00234.2013]
79 De Gottardi A,Touri F,Maurer CA,Perez A,Maurhofer O,Ventre G,Bentzen CL,Niesor EJ,Dufour JF.The bile acid nuclear receptor FXR and the bile acid binding protein IBABPare differently expressed in colon cancer.Dig Dis Sci 2004;49:982-989[PMID:15309887 DOI:10.1023/B:DDAS.0000034558.78747.98]
80 Torres J,Bao X,Iuga AC,Chen A,Harpaz N,Ullman T,Cohen BL,Pineton de Chambrun G,Asciutti S,Odin JA,Sachar DB,Gaskins HR,Setchell K,Colombel JF,Itzkowitz SH.Farnesoid Xreceptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia.Inflamm Bowel Dis 2013;19:275-282[PMID:23348121 DOI:10.1097/MIB.0b013e318286ff2e]
81 Peng Z,Raufman JP,Xie G.Src-mediated cross-talk between farnesoid X and epidermal growth factor receptors inhibits human intestinal cell proliferation and tumorigenesis.PLo S One 2012;7:e48461[PMID:23119029 DOI:10.1371/journal.pone.0048461]
82 Desnoyers LR,Pai R,Ferrando RE,H?tzel K,Le T,Ross J,Carano R,D’Souza A,Qing J,Mohtashemi I,Ashkenazi A,French DM.Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models.Oncogene 2008;27:85-97[PMID:17599042 DOI:10.1038/sj.onc.1210623]
83 Earnest DL,Holubec H,Wali RK,Jolley CS,Bissonette M,Bhattacharyya AK,Roy H,Khare S,Brasitus TA.Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid.Cancer Res 1994;54:5071-5074[PMID:7923119]
84 Jacoby RF,Cole CE,Hawk ET,Lubet RA.Ursodeoxycholate/Sulindac combination treatment effectively prevents intestinal adenomas in a mouse model of polyposis.Gastroenterology 2004;127:838-844[PMID:15362039 DOI:10.1053/j.gastro.2004.06.003]
85 Kohno H,Suzuki R,Yasui Y,Miyamoto S,Wakabayashi K,Tanaka T.Ursodeoxycholic acid versus sulfasalazine in colitisrelated colon carcinogenesis in mice.Clin Cancer Res 2007;13:2519-2525[PMID:17438113 DOI:10.1158/1078-0432.CCR-06-2727]
86 von Bergmann K,Epple-Gutsfeld M,Leiss O.Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.Gastroenterology 1984;87:136-143[PMID:6724256]
87 EstiúMC,Monte MJ,Rivas L,Moirón M,Gomez-Rodriguez L,Rodriguez-Bravo T,Marin JJ,Macias RI.Effect of ursodeoxycholic acid treatment on the altered progesterone and bile acid homeostasis in the mother-placenta-foetus trio during cholestasis of pregnancy.Br J Clin Pharmacol 2015;79:316-329[PMID:25099365 DOI:10.1111/bcp.12480]
88 Lucangioli SE,Casta?o G,Contin MD,Tripodi VP.Lithocholic acid as a biomarker of intrahepatic cholestasis of pregnancy during ursodeoxycholic acid treatment.Ann Clin Biochem 2009;46:44-49[PMID:19103957 DOI:10.1258/acb.2008.008130]
89 Hess LM,Krutzsch MF,Guillen J,Chow HH,Einspahr J,Batta AK,Salen G,Reid ME,Earnest DL,Alberts DS.Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid.Cancer Epidemiol Biomarkers Prev 2004;13:861-867[PMID:15159320]
90 Kim EK,Cho JH,Kim E,Kim YJ.Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth.PLoS One 2017;12:e0181183[PMID:28708871 DOI:10.1371/journal.pone.0181183]
91 Ochsenkühn T,Marsteller I,Hay U,Diebold J,Paumgartner G,G?ke B,Sackmann M.Does ursodeoxycholic acid change the proliferation of the colorectal mucosa?.A randomized,placebocontrolled study.Digestion 2003;68:209-216[PMID:14707397DOI:10.1159/000075927]
92 Rigas B,Tsioulias GJ,Allan C,Wali RK,Brasitus TA.The effect of bile acids and piroxicam on MHC antigen expression in rat colonocytes during colon cancer development.Immunology 1994;83:319-323[PMID:7835954]
93 Khare S,Mustafi R,Cerda S,Yuan W,Jagadeeswaran S,Dougherty U,Tretiakova M,Samarel A,Cohen G,Wang J,Moore C,Wali R,Holgren C,Joseph L,Fichera A,Li YC,Bissonnette M.Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer:roles of Ras,p38,and CCAAT/enhancer-binding protein.Nutr Cancer 2008;60:389-400[PMID:18444174 DOI:10.1080/01635580701883003]
94 Im E,Martinez JD.Ursodeoxycholic acid(UDCA)can inhibit deoxycholic acid(DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells.J Nutr 2004;134:483-486[PMID:14747693 DOI:10.1093/jn/134.2.483]
95 Shah SA,Volkov Y,Arfin Q,Abdel-Latif MM,Kelleher D.Ursodeoxycholic acid inhibits interleukin 1 beta[corrected]and deoxycholic acid-induced activation of NF-kappaB and AP-1 in human colon cancer cells.Int J Cancer 2006;118:532-539[PMID:16106402 DOI:10.1002/ijc.21365]
96 Tung BY,Emond MJ,Haggitt RC,Bronner MP,Kimmey MB,Kowdley KV,Brentnall TA.Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.Ann Intern Med 2001;134:89-95[PMID:11177311 DOI:10.7326/0003-4819-134-2-200101160-00008]
97 Huang WK,Hsu HC,Liu JR,Yang TS,Chen JS,Chang JW,Lin YC,Yu KH,Kuo CF,See LC.The Association of Ursodeoxycholic Acid Use With Colorectal Cancer Risk:A Nationwide Cohort Study.Medicine(Baltimore)2016;95:e2980[PMID:26986110DOI:10.1097/MD.0000000000002980]
98 Serfaty L,De Leusse A,Rosmorduc O,Desaint B,Flejou JF,Chazouilleres O,Poupon RE,Poupon R.Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis:an observational study.Hepatology 2003;38:203-209[PMID:12830003 DOI:10.1053/jhep.2003.50311]
99 Alberts DS,Martínez ME,Hess LM,Einspahr JG,Green SB,Bhattacharyya AK,Guillen J,Krutzsch M,Batta AK,Salen G,Fales L,Koonce K,Parish D,Clouser M,Roe D,Lance P;Phoenix and Tucson Gastroenterologist Networks.Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.J Natl Cancer Inst 2005;97:846-853[PMID:15928305 DOI:10.1093/jnci/dji144]
100 Park SE,Choi HJ,Yee SB,Chung HY,Suh H,Choi YH,Yoo YH,Kim ND.Synthetic bile acid derivatives inhibit cell proliferation and induce apoptosis in HT-29 human colon cancer cells.Int J Oncol 2004;25:231-236[PMID:15202011 DOI:10.3892/ijo.25.1.231]
101 Jonker DJ,O’Callaghan CJ,Karapetis CS,Zalcberg JR,Tu D,Au HJ,Berry SR,Krahn M,Price T,Simes RJ,Tebbutt NC,van Hazel G,Wierzbicki R,Langer C,Moore MJ.Cetuximab for the treatment of colorectal cancer.N Engl J Med 2007;357:2040-2048[PMID:18003960 DOI:10.1056/NEJMoa071834]
102 Douillard JY,Oliner KS,Siena S,Tabernero J,Burkes R,Barugel M,Humblet Y,Bodoky G,Cunningham D,Jassem J,Rivera F,Kocákova I,Ruff P,B?asińska-Morawiec M,?makal M,Canon JL,Rother M,Williams R,Rong A,Wiezorek J,Sidhu R,Patterson SD.Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer.N Engl J Med 2013;369:1023-1034[PMID:24024839 DOI:10.1056/NEJMoa1305275]
103 Sidhu GS,Oakenfull DG.A mechanism for the hypocholesterolaemic activity of saponins.Br J Nutr 1986;55:643-649[PMID:3676181DOI:10.1079/BJN19860070]
104 Lepage C,Liagre B,Cook-Moreau J,Pinon A,Beneytout JL.Cyclooxygenase-2 and 5-lipoxygenase pathways in diosgenininduced apoptosis in HT-29 and HCT-116 colon cancer cells.Int JOncol 2010;36:1183-1191[PMID:20372792]
105 Lepage C,Léger DY,Bertrand J,Martin F,Beneytout JL,Liagre B.Diosgenin induces death receptor-5 through activation of p38pathway and promotes TRAIL-induced apoptosis in colon cancer cells.Cancer Lett 2011;301:193-202[PMID:21195543 DOI:10.1016/j.canlet.2010.12.003]
106 Raju J,Patlolla JM,Swamy MV,Rao CV.Diosgenin,a steroid saponin of Trigonella foenum graecum(Fenugreek),inhibits azoxymethane-induced aberrant crypt foci formation in F344rats and induces apoptosis in HT-29 human colon cancer cells.Cancer Epidemiol Biomarkers Prev 2004;13:1392-1398[PMID:15298963]
107 Singh M,Singh A,Kundu S,Bansal S,Bajaj A.Deciphering the role of charge,hydration,and hydrophobicity for cytotoxic activities and membrane interactions of bile acid based facial amphiphiles.Biochim Biophys Acta 2013;1828:1926-1937[PMID:23590996 DOI:10.1016/j.bbamem.2013.04.003]
108 Singh M,Bansal S,Kundu S,Bhargava P,Singh A,Motiani RK,Shyam R,Sreekanth V,Sengupta S,Bajaj A.Synthesis,StructureActivity Relationship,and Mechanistic Investigation of Lithocholic Acid Amphiphiles for Colon Cancer Therapy.Medchemcomm2015;6:192-201[PMID:25685308 DOI:10.1039/C4MD00223G]
2 Schaap FG,Trauner M,Jansen PL.Bile acid receptors as targets for drug development.Nat Rev Gastroenterol Hepatol 2014;11:55-67[PMID:23982684 DOI:10.1038/nrgastro.2013.151]
3 Mertens KL,Kalsbeek A,Soeters MR,Eggink HM.Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System.Front Neurosci 2017;11:617[PMID:29163019 DOI:10.3389/fnins.2017.00617]
4 Kullak-Ublick GA,Stieger B,Meier PJ.Enterohepatic bile salt transporters in normal physiology and liver disease.Gastroenterology 2004;126:322-342[PMID:14699511 DOI:10.1053/j.gastro.2003.06.005]
5 Li T,Chiang JY.Bile acid signaling in metabolic disease and drug therapy.Pharmacol Rev 2014;66:948-983[PMID:25073467DOI:10.1124/pr.113.008201]
6 Thomas C,Pellicciari R,Pruzanski M,Auwerx J,Schoonjans K.Targeting bile-acid signalling for metabolic diseases.Nat Rev Drug Discov 2008;7:678-693[PMID:18670431 DOI:10.1038/nrd2619]
7 Chiang JY.Regulation of bile acid synthesis:pathways,nuclear receptors,and mechanisms.J Hepatol 2004;40:539-551[PMID:15123373 DOI:10.1016/j.jhep.2003.11.006]
8 Twisk J,Hoekman MF,Lehmann EM,Meijer P,Mager WH,Princen HM.Insulin suppresses bile acid synthesis in cultured rat hepatocytes by down-regulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase gene transcription.Hepatology 1995;21:501-510[PMID:7843724]
9 Song Y,Xu C,Shao S,Liu J,Xing W,Xu J,Qin C,Li C,Hu B,Yi S,Xia X,Zhang H,Zhang X,Wang T,Pan W,Yu C,Wang Q,Lin X,Wang L,Gao L,Zhao J.Thyroid-stimulating hormone regulates hepatic bile acid homeostasis via SREBP-2/HNF-4α/CYP7A1 axis.J Hepatol 2015;62:1171-1179[PMID:25533663 DOI:10.1016/j.jhep.2014.12.006]
10 Wagner M,Halilbasic E,Marschall HU,Zollner G,Fickert P,Langner C,Zatloukal K,Denk H,Trauner M.CAR and PXRagonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.Hepatology 2005;42:420-430[PMID:15986414 DOI:10.1002/hep.20784]
11 Li T,Chiang JY.Mechanism of rifampicin and pregnane Xreceptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription.Am J Physiol Gastrointest Liver Physiol 2005;288:G74-G84[PMID:15331348 DOI:10.1152/ajpgi.00258.2004]
12 Bhalla S,Ozalp C,Fang S,Xiang L,Kemper JK.Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha.Functional implications in hepatic cholesterol and glucose metabolism.J Biol Chem2004;279:45139-45147[PMID:15322103 DOI:10.1074/jbc.M405423200]
13 Vlachova M,Blahova T,Lanska V,Lení?ek M,Pitha J,Vítek L,Kovar J.Diurnal variation in cholesterol 7α-hydroxylase activity is determined by the-203A>C polymorphism of the CYP7A1gene.Croat Med J 2016;57:111-117[PMID:27106353 DOI:10.3325/cmj.2016.57.111]
14 Kovár J,Lenícek M,ZimolováM,Vítek L,Jirsa M,Pitha J.Regulation of diurnal variation of cholesterol 7alpha-hydroxylase(CYP7A1)activity in healthy subjects.Physiol Res 2010;59:233-238[PMID:19537927]
15 Nagengast FM,Grubben MJ,van Munster IP.Role of bile acids in colorectal carcinogenesis.Eur J Cancer 1995;31:1067-1070[PMID:7576993 DOI:10.1016/0959-8049(95)00216-6]
16 Bayerd?rffer E,Mannes GA,Richter WO,Ochsenkühn T,Wiebecke B,K?pcke W,Paumgartner G.Increased serum deoxycholic acid levels in men with colorectal adenomas.Gastroenterology 1993;104:145-151[PMID:8419237 DOI:10.1016/0016-5085(93)90846-5]
17 Bayerd?rffer E,Mannes GA,Ochsenkühn T,Dirschedl P,Wiebecke B,Paumgartner G.Unconjugated secondary bile acids in the serum of patients with colorectal adenomas.Gut 1995;36:268-273[PMID:7883228 DOI:10.1136/gut.36.2.268]
18 Tong JL,Ran ZH,Shen J,Fan GQ,Xiao SD.Association between fecal bile acids and colorectal cancer:a meta-analysis of observational studies.Yonsei Med J 2008;49:792-803[PMID:18972600 DOI:10.3349/ymj.2008.49.5.792]
19 Imray CH,Radley S,Davis A,Barker G,Hendrickse CW,Donovan IA,Lawson AM,Baker PR,Neoptolemos JP.Faecal unconjugated bile acids in patients with colorectal cancer or polyps.Gut 1992;33:1239-1245[PMID:1427378 DOI:10.1136/gut.33.9.1239]
20 Kirkegaard H,Johnsen NF,Christensen J,Frederiksen K,Overvad K,Tj?nneland A.Association of adherence to lifestyle recommendations and risk of colorectal cancer:a prospective Danish cohort study.BMJ 2010;341:c5504[PMID:20978063DOI:10.1136/bmj.c5504]
21 Jenkins DJ,Wolever TM,Rao AV,Hegele RA,Mitchell SJ,Ransom TP,Boctor DL,Spadafora PJ,Jenkins AL,Mehling C.Effect on blood lipids of very high intakes of fiber in diets low in saturated fat and cholesterol.N Engl J Med 1993;329:21-26[PMID:8389421 DOI:10.1056/NEJM199307013290104]
22 Ghaffarzadegan T,Zhong Y,F?k H?llenius F,Nyman M.Effects of barley variety,dietary fiber andβ-glucan content on bile acid composition in cecum of rats fed low-and high-fat diets.J Nutr Biochem 2018;53:104-110[PMID:29202273 DOI:10.1016/j.jnutbio.2017.10.008]
23 Newmark HL,Yang K,Kurihara N,Fan K,Augenlicht LH,Lipkin M.Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice:a preclinical model for human sporadic colon cancer.Carcinogenesis 2009;30:88-92[PMID:19017685 DOI:10.1093/carcin/bgn229]
24 Thummel KE,Brimer C,Yasuda K,Thottassery J,Senn T,Lin Y,Ishizuka H,Kharasch E,Schuetz J,Schuetz E.Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3.Mol Pharmacol 2001;60:1399-1406[PMID:11723248 DOI:10.1124/mol.60.6.1399]
25 Kawaura A,Tanida N,Sawada K,Oda M,Shimoyama T.Supplemental administration of 1 alpha-hydroxyvitamin D3inhibits promotion by intrarectal instillation of lithocholic acid in N-methyl-N-nitrosourea-induced colonic tumorigenesis in rats.Carcinogenesis 1989;10:647-649[PMID:2702712 DOI:10.1093/carcin/10.4.647]
26 Makishima M,Lu TT,Xie W,Whitfield GK,Domoto H,Evans RM,Haussler MR,Mangelsdorf DJ.Vitamin D receptor as an intestinal bile acid sensor.Science 2002;296:1313-1316[PMID:12016314 DOI:10.1126/science.1070477]
27 Newmark HL,Wargovich MJ,Bruce WR.Colon cancer and dietary fat,phosphate,and calcium:a hypothesis.J Natl Cancer Inst 1984;72:1323-1325[PMID:6587152]
28 Payne CM,Bernstein C,Dvorak K,Bernstein H.Hydrophobic bile acids,genomic instability,Darwinian selection,and colon carcinogenesis.Clin Exp Gastroenterol 2008;1:19-47[PMID:21677822 DOI:10.2147/CEG.S4343]
29 Ochsenkühn T,Bayerd?rffer E,Meining A,Schinkel M,Thiede C,Nüssler V,Sackmann M,Hatz R,Neubauer A,Paumgartner G.Colonic mucosal proliferation is related to serum deoxycholic acid levels.Cancer 1999;85:1664-1669[PMID:10223558DOI:10.1002/(SICI)1097-0142(19990415)85:8<1664::AID-CNCR4>3.0.CO;2-O]
30 Ajouz H,Mukherji D,Shamseddine A.Secondary bile acids:an underrecognized cause of colon cancer.World J Surg Oncol 2014;12:164[PMID:24884764 DOI:10.1186/1477-7819-12-164]
31 Degirolamo C,Modica S,Palasciano G,Moschetta A.Bile acids and colon cancer:Solving the puzzle with nuclear receptors.Trends Mol Med 2011;17:564-572[PMID:21724466 DOI:10.1016/j.molmed.2011.05.010]
32 Bernstein H,Bernstein C,Payne CM,Dvorak K.Bile acids as endogenous etiologic agents in gastrointestinal cancer.World J Gastroenterol 2009;15:3329-3340[PMID:19610133 DOI:10.3748/wjg.15.3329]
33 Qiao D,Gaitonde SV,Qi W,Martinez JD.Deoxycholic acid suppresses p53 by stimulating proteasome-mediated p53 protein degradation.Carcinogenesis 2001;22:957-964[PMID:11375905DOI:10.1093/carcin/22.6.957]
34 Turner DJ,Alaish SM,Zou T,Rao JN,Wang JY,Strauch ED.Bile salts induce resistance to apoptosis through NF-kappaB-mediated XIAP expression.Ann Surg 2007;245:415-425[PMID:17435549DOI:10.1097/01.sla.0000236631.72698.99]
35 Farhana L,Nangia-Makker P,Arbit E,Shango K,Sarkar S,Mahmud H,Hadden T,Yu Y,Majumdar AP.Bile acid:a potential inducer of colon cancer stem cells.Stem Cell Res Ther 2016;7:181[PMID:27908290 DOI:10.1186/s13287-016-0439-4]
36 Rodrigues C?MP,Castro RE,Steer CJ.The role of bile acids in the modulation of apoptosis:Elsevier Ltd,2004,15:119-145
37 Ignacio Barrasa J,Olmo N,Pérez-Ramos P,Santiago-Gómez A,Lecona E,Turnay J,Antonia Lizarbe M.Deoxycholic and chenodeoxycholic bile acids induce apoptosis via oxidative stress in human colon adenocarcinoma cells.Apoptosis 2011;16:1054-1067[PMID:21789651 DOI:10.1007/s10495-011-0633-x]
38 Yui S,Kanamoto R,Saeki T.Biphasic regulation of cell death and survival by hydrophobic bile acids in HCT116 cells.Nutr Cancer2009;61:374-380[PMID:19373611 DOI:10.1080/01635580802582744]
39 Shant J,Cheng K,Marasa BS,Wang JY,Raufman JP.Aktdependent NF-kappaB activation is required for bile acids to rescue colon cancer cells from stress-induced apoptosis.Exp Cell Res 2009;315:432-450[PMID:19056378 DOI:10.1016/j.yexcr.2008.11.003]
40 Raufman JP,Shant J,Guo CY,Roy S,Cheng K.Deoxycholyltaurine rescues human colon cancer cells from apoptosis by activating EGFR-dependent PI3K/Akt signaling.J Cell Physiol 2008;215:538-549[PMID:18064605 DOI:10.1002/jcp.21332]
41 Cheng K,Raufman JP.Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors.Biochem Pharmacol 2005;70:1035-1047[PMID:16139803 DOI:10.1016/j.bcp.2005.07.023]
42 Cao H,Luo S,Xu M,Zhang Y,Song S,Wang S,Kong X,He N,Cao X,Yan F,Wang B.The secondary bile acid,deoxycholate accelerates intestinal adenoma-adenocarcinoma sequence in Apc(min/+)mice through enhancing Wnt signaling.Fam Cancer 2014;13:563-571[PMID:25106466 DOI:10.1007/s10689-014-9742-3]
43 Dermadi D,Valo S,Ollila S,Soliymani R,Sipari N,Pussila M,Sarantaus L,Linden J,Baumann M,Nystr?m M.Western Diet Deregulates Bile Acid Homeostasis,Cell Proliferation,and Tumorigenesis in Colon.Cancer Res 2017;77:3352-3363[PMID:28416481 DOI:10.1158/0008-5472.CAN-16-2860]
44 Pai R,Tarnawski AS,Tran T.Deoxycholic acid activates betacatenin signaling pathway and increases colon cell cancer growth and invasiveness.Mol Biol Cell 2004;15:2156-2163[PMID:15004225 DOI:10.1091/mbc.e03-12-0894]
45 Baek MK,Park JS,Park JH,Kim MH,Kim HD,Bae WK,Chung IJ,Shin BA,Jung YD.Lithocholic acid upregulates uPAR and cell invasiveness via MAPK and AP-1 signaling in colon cancer cells.Cancer Lett 2010;290:123-128[PMID:19782465 DOI:10.1016/j.canlet.2009.08.030]
46 Debruyne PR,Bruyneel EA,Karaguni IM,Li X,Flatau G,Müller O,Zimber A,Gespach C,Mareel MM.Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathways.Oncogene 2002;21:6740-6750[PMID:12360401 DOI:10.1038/sj.onc.1205729]
47 Nishida N,Yano H,Nishida T,Kamura T,Kojiro M.Angiogenesis in cancer.Vasc Health Risk Manag 2006;2:213-219[PMID:17326328 DOI:10.2147/vhrm.2006.2.3.213]
48 Mühlbauer M,Allard B,Bosserhoff AK,Kiessling S,Herfarth H,Rogler G,Sch?lmerich J,Jobin C,Hellerbrand C.Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-kappa B signal transduction and IL-8 gene expression in colonic epithelial cells.Am J Physiol Gastrointest Liver Physiol 2004;286:G1000-G1008[PMID:14726307 DOI:10.1152/ajpgi.00338.2003]
49 Nguyen TT,Lian S,Ung TT,Xia Y,Han JY,Jung YD.Lithocholic Acid Stimulates IL-8 Expression in Human Colorectal Cancer Cells Via Activation of Erk1/2 MAPK and Suppression of STAT3Activity.J Cell Biochem 2017;118:2958-2967[PMID:28247965DOI:10.1002/jcb.25955]
50 Per?e M.Oxidative stress in the pathogenesis of colorectal cancer:cause or consequence?Biomed Res Int 2013;2013:725710[PMID:23762854 DOI:10.1155/2013/725710]
51 Ji LL,Gomez-Cabrera MC,Vina J.Exercise and hormesis:activation of cellular antioxidant signaling pathway.Ann N YAcad Sci 2006;1067:425-435[PMID:16804022 DOI:10.1196/annals.1354.061]
52 Ji LL,Gomez-Cabrera MC,Vina J.Role of nuclear factor kappaBand mitogen-activated protein kinase signaling in exercise-induced antioxidant enzyme adaptation.Appl Physiol Nutr Metab 2007;32:930-935[PMID:18059618 DOI:10.1139/H07-098]
53 Payne CM,Weber C,Crowley-Skillicorn C,Dvorak K,Bernstein H,Bernstein C,Holubec H,Dvorakova B,Garewal H.Deoxycholate induces mitochondrial oxidative stress and activates NF-kappaBthrough multiple mechanisms in HCT-116 colon epithelial cells.Carcinogenesis 2007;28:215-222[PMID:16887864 DOI:10.1093/carcin/bgl139]
54 Valko M,Leibfritz D,Moncol J,Cronin MT,Mazur M,Telser J.Free radicals and antioxidants in normal physiological functions and human disease.Int J Biochem Cell Biol 2007;39:44-84[PMID:16978905 DOI:10.1016/j.biocel.2006.07.001]
55 Roberts RB,Min L,Washington MK,Olsen SJ,Settle SH,Coffey RJ,Threadgill DW.Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis.Proc Natl Acad Sci U S A 2002;99:1521-1526[PMID:11818567 DOI:10.1073/pnas.032678499]
56 Nicholson RI,Gee JM,Harper ME.EGFR and cancer prognosis.Eur J Cancer 2001;37 Suppl 4:S9-S15[PMID:11597399 DOI:10.1016/S0959-8049(01)00231-3]
57 Lee HY,Crawley S,Hokari R,Kwon S,Kim YS.Bile acid regulates MUC2 transcription in colon cancer cells via positive EGFR/PKC/Ras/ERK/CREB,PI3K/Akt/IkappaB/NF-kappaBand p38/MSK1/CREB pathways and negative JNK/c-Jun/AP-1pathway.Int J Oncol 2010;36:941-953[PMID:20198339]
58 Musteanu M,Blaas L,Mair M,Schlederer M,Bilban M,Tauber S,Esterbauer H,Mueller M,Casanova E,Kenner L,Poli V,Eferl R.Stat3 is a negative regulator of intestinal tumor progression in Apc(Min)mice.Gastroenterology 2010;138:1003-1011.e1-e5[PMID:19962983 DOI:10.1053/j.gastro.2009.11.049]
59 de Jong PR,Mo JH,Harris AR,Lee J,Raz E.STAT3:An AntiInvasive Factor in Colorectal Cancer?Cancers(Basel)2014;6:1394-1407[PMID:24995503 DOI:10.3390/cancers6031394]
60 Parsons DW,Wang TL,Samuels Y,Bardelli A,Cummins JM,De Long L,Silliman N,Ptak J,Szabo S,Willson JK,Markowitz S,Kinzler KW,Vogelstein B,Lengauer C,Velculescu VE.Colorectal cancer:mutations in a signalling pathway.Nature 2005;436:792[PMID:16094359 DOI:10.1038/436792a]
61 Tucker ON,Dannenberg AJ,Yang EK,Fahey TJ 3rd.Bile acids induce cyclooxygenase-2 expression in human pancreatic cancer cell lines.Carcinogenesis 2004;25:419-423[PMID:14656949DOI:10.1093/carcin/bgh010]
62 Zhu Y,Hua P,Rafiq S,Waffner EJ,Duffey ME,Lance P.Ca2+-and PKC-dependent stimulation of PGE2 synthesis by deoxycholic acid in human colonic fibroblasts.Am J Physiol Gastrointest Liver Physiol 2002;283:G503-G510[PMID:12181161 DOI:10.1152/ajpgi.00525.2001]
63 Cheng K,Chen Y,Zimniak P,Raufman JP,Xiao Y,Frucht H.Functional interaction of lithocholic acid conjugates with M3muscarinic receptors on a human colon cancer cell line.Biochim Biophys Acta 2002;1588:48-55[PMID:12379313 DOI:10.1016/S0925-4439(02)00115-1]
64 Cheng K,Xie G,Raufman JP.Matrix metalloproteinase-7-catalyzed release of HB-EGF mediates deoxycholyltaurineinduced proliferation of a human colon cancer cell line.Biochem Pharmacol 2007;73:1001-1012[PMID:17222808 DOI:10.1016/j.bcp.2006.11.028]
65 Raufman JP,Cheng K,Saxena N,Chahdi A,Belo A,Khurana S,Xie G.Muscarinic receptor agonists stimulate matrix metalloproteinase 1-dependent invasion of human colon cancer cells.Biochem Biophys Res Commun 2011;415:319-324[PMID:22027145 DOI:10.1016/j.bbrc.2011.10.052]
66 Arvind P,Papavassiliou ED,Tsioulias GJ,Duceman BW,Lovelace CI,Geng W,Staiano-Coico L,Rigas B.Lithocholic acid inhibits the expression of HLA class I genes in colon adenocarcinoma cells.Differential effect on HLA-A,-B and-Cloci.Mol Immunol 1994;31:607-614[PMID:8196671 DOI:10.1016/0161-5890(94)90168-6]
67 Halvorsen B,Staff AC,Ligaarden S,Prydz K,Kolset SO.Lithocholic acid and sulphated lithocholic acid differ in the ability to promote matrix metalloproteinase secretion in the human colon cancer cell line CaCo-2.Biochem J 2000;349:189-193[PMID:10861227 DOI:10.1042/bj3490189]
68 Jurek D,Fleckl E,Marian B.Bile acid induced gene expression in LT97 colonic adenoma cells.Food Chem Toxicol 2005;43:87-93[PMID:15582199 DOI:10.1016/j.fct.2004.08.015]
69 Oshio H,Abe T,Onogawa T,Ohtsuka H,Sato T,Ii T,Fukase K,Muto M,Katayose Y,Oikawa M,Rikiyama T,Egawa S,Unno M.Peroxisome proliferator-activated receptor alpha activates cyclooxygenase-2 gene transcription through bile acid transport in human colorectal cancer cell lines.J Gastroenterol 2008;43:538-549[PMID:18648741 DOI:10.1007/s00535-008-2188-3]
70 Zhu Y,Zhu M,Lance P.Stromal COX-2 signaling activated by deoxycholic acid mediates proliferation and invasiveness of colorectal epithelial cancer cells.Biochem Biophys Res Commun 2012;425:607-612[PMID:22885178 DOI:10.1016/j.bbrc.2012.07.137]
71 Glinghammar B,Rafter J.Colonic luminal contents induce cyclooxygenase 2 transcription in human colon carcinoma cells.Gastroenterology 2001;120:401-410[PMID:11159881 DOI:10.1053/gast.2001.21188]
72 Rial NS,Lazennec G,Prasad AR,Krouse RS,Lance P,Gerner EW.Regulation of deoxycholate induction of CXCL8 by the adenomatous polyposis coli gene in colorectal cancer.Int J Cancer2009;124:2270-2280[PMID:19173296 DOI:10.1002/ijc.24226]
73 Wang JY,Wang CL,Wang XM,Liu FJ.Comprehensive analysis of microRNA/mRNA signature in colon adenocarcinoma.Eur Rev Med Pharmacol Sci 2017;21:2114-2129[PMID:28537673]
74 Krattinger R,Bostr?m A,Lee SML,Thasler WE,Schi?th HB,Kullak-Ublick GA,Mwinyi J.Chenodeoxycholic acid significantly impacts the expression of miRNAs and genes involved in lipid,bile acid and drug metabolism in human hepatocytes.Life Sci 2016;156:47-56[PMID:27174168 DOI:10.1016/j.lfs.2016.04.037]
75 Dixit AK,Sarver AE,Yuan Z,George J,Barlass U,Cheema H,Sareen A,Banerjee S,Dudeja V,Dawra R,Subramanian S,Saluja AK.Comprehensive analysis of microRNA signature of mouse pancreatic acini:overexpression of miR-21-3p in acute pancreatitis.Am J Physiol Gastrointest Liver Physiol 2016;311:G974-G980[PMID:27686613 DOI:10.1152/ajpgi.00191.2016]
76 Castro RE,Ferreira DM,Zhang X,Borralho PM,Sarver AL,Zeng Y,Steer CJ,Kren BT,Rodrigues CM.Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid.Am J Physiol Gastrointest Liver Physiol 2010;299:G887-G897[PMID:20689055 DOI:10.1152/ajpgi.00216.2010]
77 Kong Y,Bai PS,Sun H,Nan KJ,Chen NZ,Qi XG.The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.Int J Biochem Cell Biol 2012;44:2321-2332[PMID:22903020 DOI:10.1016/j.biocel.2012.08.006]
78 Bailey AM,Zhan L,Maru D,Shureiqi I,Pickering CR,Kiriakova G,Izzo J,He N,Wei C,Baladandayuthapani V,Liang H,Kopetz S,Powis G,Guo GL.FXR silencing in human colon cancer by DNAmethylation and KRAS signaling.Am J Physiol Gastrointest Liver Physiol 2014;306:G48-G58[PMID:24177031 DOI:10.1152/ajpgi.00234.2013]
79 De Gottardi A,Touri F,Maurer CA,Perez A,Maurhofer O,Ventre G,Bentzen CL,Niesor EJ,Dufour JF.The bile acid nuclear receptor FXR and the bile acid binding protein IBABPare differently expressed in colon cancer.Dig Dis Sci 2004;49:982-989[PMID:15309887 DOI:10.1023/B:DDAS.0000034558.78747.98]
80 Torres J,Bao X,Iuga AC,Chen A,Harpaz N,Ullman T,Cohen BL,Pineton de Chambrun G,Asciutti S,Odin JA,Sachar DB,Gaskins HR,Setchell K,Colombel JF,Itzkowitz SH.Farnesoid Xreceptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia.Inflamm Bowel Dis 2013;19:275-282[PMID:23348121 DOI:10.1097/MIB.0b013e318286ff2e]
81 Peng Z,Raufman JP,Xie G.Src-mediated cross-talk between farnesoid X and epidermal growth factor receptors inhibits human intestinal cell proliferation and tumorigenesis.PLo S One 2012;7:e48461[PMID:23119029 DOI:10.1371/journal.pone.0048461]
82 Desnoyers LR,Pai R,Ferrando RE,H?tzel K,Le T,Ross J,Carano R,D’Souza A,Qing J,Mohtashemi I,Ashkenazi A,French DM.Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models.Oncogene 2008;27:85-97[PMID:17599042 DOI:10.1038/sj.onc.1210623]
83 Earnest DL,Holubec H,Wali RK,Jolley CS,Bissonette M,Bhattacharyya AK,Roy H,Khare S,Brasitus TA.Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid.Cancer Res 1994;54:5071-5074[PMID:7923119]
84 Jacoby RF,Cole CE,Hawk ET,Lubet RA.Ursodeoxycholate/Sulindac combination treatment effectively prevents intestinal adenomas in a mouse model of polyposis.Gastroenterology 2004;127:838-844[PMID:15362039 DOI:10.1053/j.gastro.2004.06.003]
85 Kohno H,Suzuki R,Yasui Y,Miyamoto S,Wakabayashi K,Tanaka T.Ursodeoxycholic acid versus sulfasalazine in colitisrelated colon carcinogenesis in mice.Clin Cancer Res 2007;13:2519-2525[PMID:17438113 DOI:10.1158/1078-0432.CCR-06-2727]
86 von Bergmann K,Epple-Gutsfeld M,Leiss O.Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.Gastroenterology 1984;87:136-143[PMID:6724256]
87 EstiúMC,Monte MJ,Rivas L,Moirón M,Gomez-Rodriguez L,Rodriguez-Bravo T,Marin JJ,Macias RI.Effect of ursodeoxycholic acid treatment on the altered progesterone and bile acid homeostasis in the mother-placenta-foetus trio during cholestasis of pregnancy.Br J Clin Pharmacol 2015;79:316-329[PMID:25099365 DOI:10.1111/bcp.12480]
88 Lucangioli SE,Casta?o G,Contin MD,Tripodi VP.Lithocholic acid as a biomarker of intrahepatic cholestasis of pregnancy during ursodeoxycholic acid treatment.Ann Clin Biochem 2009;46:44-49[PMID:19103957 DOI:10.1258/acb.2008.008130]
89 Hess LM,Krutzsch MF,Guillen J,Chow HH,Einspahr J,Batta AK,Salen G,Reid ME,Earnest DL,Alberts DS.Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid.Cancer Epidemiol Biomarkers Prev 2004;13:861-867[PMID:15159320]
90 Kim EK,Cho JH,Kim E,Kim YJ.Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth.PLoS One 2017;12:e0181183[PMID:28708871 DOI:10.1371/journal.pone.0181183]
91 Ochsenkühn T,Marsteller I,Hay U,Diebold J,Paumgartner G,G?ke B,Sackmann M.Does ursodeoxycholic acid change the proliferation of the colorectal mucosa?.A randomized,placebocontrolled study.Digestion 2003;68:209-216[PMID:14707397DOI:10.1159/000075927]
92 Rigas B,Tsioulias GJ,Allan C,Wali RK,Brasitus TA.The effect of bile acids and piroxicam on MHC antigen expression in rat colonocytes during colon cancer development.Immunology 1994;83:319-323[PMID:7835954]
93 Khare S,Mustafi R,Cerda S,Yuan W,Jagadeeswaran S,Dougherty U,Tretiakova M,Samarel A,Cohen G,Wang J,Moore C,Wali R,Holgren C,Joseph L,Fichera A,Li YC,Bissonnette M.Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer:roles of Ras,p38,and CCAAT/enhancer-binding protein.Nutr Cancer 2008;60:389-400[PMID:18444174 DOI:10.1080/01635580701883003]
94 Im E,Martinez JD.Ursodeoxycholic acid(UDCA)can inhibit deoxycholic acid(DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells.J Nutr 2004;134:483-486[PMID:14747693 DOI:10.1093/jn/134.2.483]
95 Shah SA,Volkov Y,Arfin Q,Abdel-Latif MM,Kelleher D.Ursodeoxycholic acid inhibits interleukin 1 beta[corrected]and deoxycholic acid-induced activation of NF-kappaB and AP-1 in human colon cancer cells.Int J Cancer 2006;118:532-539[PMID:16106402 DOI:10.1002/ijc.21365]
96 Tung BY,Emond MJ,Haggitt RC,Bronner MP,Kimmey MB,Kowdley KV,Brentnall TA.Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.Ann Intern Med 2001;134:89-95[PMID:11177311 DOI:10.7326/0003-4819-134-2-200101160-00008]
97 Huang WK,Hsu HC,Liu JR,Yang TS,Chen JS,Chang JW,Lin YC,Yu KH,Kuo CF,See LC.The Association of Ursodeoxycholic Acid Use With Colorectal Cancer Risk:A Nationwide Cohort Study.Medicine(Baltimore)2016;95:e2980[PMID:26986110DOI:10.1097/MD.0000000000002980]
98 Serfaty L,De Leusse A,Rosmorduc O,Desaint B,Flejou JF,Chazouilleres O,Poupon RE,Poupon R.Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis:an observational study.Hepatology 2003;38:203-209[PMID:12830003 DOI:10.1053/jhep.2003.50311]
99 Alberts DS,Martínez ME,Hess LM,Einspahr JG,Green SB,Bhattacharyya AK,Guillen J,Krutzsch M,Batta AK,Salen G,Fales L,Koonce K,Parish D,Clouser M,Roe D,Lance P;Phoenix and Tucson Gastroenterologist Networks.Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.J Natl Cancer Inst 2005;97:846-853[PMID:15928305 DOI:10.1093/jnci/dji144]
100 Park SE,Choi HJ,Yee SB,Chung HY,Suh H,Choi YH,Yoo YH,Kim ND.Synthetic bile acid derivatives inhibit cell proliferation and induce apoptosis in HT-29 human colon cancer cells.Int J Oncol 2004;25:231-236[PMID:15202011 DOI:10.3892/ijo.25.1.231]
101 Jonker DJ,O’Callaghan CJ,Karapetis CS,Zalcberg JR,Tu D,Au HJ,Berry SR,Krahn M,Price T,Simes RJ,Tebbutt NC,van Hazel G,Wierzbicki R,Langer C,Moore MJ.Cetuximab for the treatment of colorectal cancer.N Engl J Med 2007;357:2040-2048[PMID:18003960 DOI:10.1056/NEJMoa071834]
102 Douillard JY,Oliner KS,Siena S,Tabernero J,Burkes R,Barugel M,Humblet Y,Bodoky G,Cunningham D,Jassem J,Rivera F,Kocákova I,Ruff P,B?asińska-Morawiec M,?makal M,Canon JL,Rother M,Williams R,Rong A,Wiezorek J,Sidhu R,Patterson SD.Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer.N Engl J Med 2013;369:1023-1034[PMID:24024839 DOI:10.1056/NEJMoa1305275]
103 Sidhu GS,Oakenfull DG.A mechanism for the hypocholesterolaemic activity of saponins.Br J Nutr 1986;55:643-649[PMID:3676181DOI:10.1079/BJN19860070]
104 Lepage C,Liagre B,Cook-Moreau J,Pinon A,Beneytout JL.Cyclooxygenase-2 and 5-lipoxygenase pathways in diosgenininduced apoptosis in HT-29 and HCT-116 colon cancer cells.Int JOncol 2010;36:1183-1191[PMID:20372792]
105 Lepage C,Léger DY,Bertrand J,Martin F,Beneytout JL,Liagre B.Diosgenin induces death receptor-5 through activation of p38pathway and promotes TRAIL-induced apoptosis in colon cancer cells.Cancer Lett 2011;301:193-202[PMID:21195543 DOI:10.1016/j.canlet.2010.12.003]
106 Raju J,Patlolla JM,Swamy MV,Rao CV.Diosgenin,a steroid saponin of Trigonella foenum graecum(Fenugreek),inhibits azoxymethane-induced aberrant crypt foci formation in F344rats and induces apoptosis in HT-29 human colon cancer cells.Cancer Epidemiol Biomarkers Prev 2004;13:1392-1398[PMID:15298963]
107 Singh M,Singh A,Kundu S,Bansal S,Bajaj A.Deciphering the role of charge,hydration,and hydrophobicity for cytotoxic activities and membrane interactions of bile acid based facial amphiphiles.Biochim Biophys Acta 2013;1828:1926-1937[PMID:23590996 DOI:10.1016/j.bbamem.2013.04.003]
108 Singh M,Bansal S,Kundu S,Bhargava P,Singh A,Motiani RK,Shyam R,Sreekanth V,Sengupta S,Bajaj A.Synthesis,StructureActivity Relationship,and Mechanistic Investigation of Lithocholic Acid Amphiphiles for Colon Cancer Therapy.Medchemcomm2015;6:192-201[PMID:25685308 DOI:10.1039/C4MD00223G]